Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cytokinetics (CYTK) Interest Expenses (2016 - 2025)

Cytokinetics (CYTK) has disclosed Interest Expenses for 13 consecutive years, with $16.8 million as the latest value for Q4 2025.

  • Quarterly Interest Expenses changed N/A to $16.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $39.3 million through Dec 2025, changed N/A year-over-year, with the annual reading at $45.6 million for FY2025, 20.9% up from the prior year.
  • Interest Expenses for Q4 2025 was $16.8 million at Cytokinetics, up from $11.4 million in the prior quarter.
  • The five-year high for Interest Expenses was $16.8 million in Q4 2025, with the low at $2.7 million in Q1 2022.
  • Average Interest Expenses over 5 years is $7.3 million, with a median of $7.1 million recorded in 2022.
  • The sharpest move saw Interest Expenses plummeted 31.14% in 2022, then skyrocketed 153.5% in 2023.
  • Over 5 years, Interest Expenses stood at $4.2 million in 2021, then soared by 67.31% to $7.1 million in 2022, then grew by 1.52% to $7.2 million in 2023, then increased by 24.62% to $8.9 million in 2024, then skyrocketed by 88.35% to $16.8 million in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $16.8 million, $11.4 million, and $11.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.